afatinibosimertinibNon-small cell lung cancerNSCLC
…age in terms of PFS, it has a high incremental cost compared to afatinib. Therefore, the treatment is not cost-effective based on the th…
Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…age in terms of PFS, it has a high incremental cost compared to afatinib. Therefore, the treatment is not cost-effective based on the th…
…data from 2014 to 2024, focusing on ‘TEN’ and ‘SJS’ ADRs due to afatinib. Since TEN is a more severe form of SJS, the reactions were gro…